The Bulgarian Competition Authority finds that a medical institution abused its dominance by refusing to deal with a nuclear medicine laboratory (UMBAL - Dr. Georgi Stranski)

Competition Authority, Bulgarian

Previous article The Polish Competition Authority investigates the data processing policy of a Big Tech company (Apple) Next article The Italian Competition Authority imposes a record fine of over €1 billion as well as behavioral remedies on an e-commerce company for abusing its dominant position through engaging in discriminatory practices and denying third-party sellers access to certain sales prospects crucial to increasing their visibility on its website (Amazon)

10 Dec 2021

The Bulgarian Competition Authority finds that a medical institution abused its dominance by refusing to deal with a nuclear medicine laboratory (UMBAL - Dr. Georgi Stranski)

KEYWORDS

Reference

Bulgarian Competition Authority, UMBAL - Dr. Georgi Stranski, Press Release, 10 December 2021

The Commission for the Protection of Competition found abuse of a dominant position by "UMBAL - Dr. Georgi Stranski" EAD* With Decision No. 1204 /09.12.2021 , issued on file No. KZK-228/2020, the KZK found that "UMBAL - Dr. Georgi Stranski" EAD committed an abuse of a dominant position by refusing to conclude a contract for the provision of services

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Bulgarian Competition Authority
Bulgarian Commission for the Protection of Competition (Sofia)

Bulgaria 13 contributions 1630 visits

Quotation

Bulgarian Competition Authority, The Bulgarian Competition Authority finds that a medical institution abused its dominance by refusing to deal with a nuclear medicine laboratory (UMBAL - Dr. Georgi Stranski), 10 December 2021, e-Competitions December 2021, Art. N° 107810

Visites 8